Skip to content
Advertisement

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

President Joe Biden delivers remarks on COVID-19 during an event in the South Court Auditorium on the White House campus, Monday, Sept. 27, 2021, in Washington. (AP Photo/Evan Vucci)

Biden on high-stakes week ahead: ‘I’m a born optimist’

President Biden didn't flinch as he received a COVID-19 booster shot Monday, but the week ahead is far scarier for his party and his presidential legacy, as Washington faces the prospect of a government shutdown, default on its debts and pivotal votes on infrastructure and social welfare spending at the center of the Democrats' agenda. Published September 27, 2021

President Joe Biden receives a COVID-19 booster shot during an event in the South Court Auditorium on the White House campus, Monday, Sept. 27, 2021, in Washington. (AP Photo/Evan Vucci)

Biden gets a COVID-19 booster shot in front of cameras

President Biden received a booster shot of a COVID-19 vaccine in front of the cameras Monday, hoping to set a high-profile example after he prodded regulators to approve extra doses to stiff-arm the virus ahead of winter. Published September 27, 2021

In this Dec. 10, 2020, file photo, Food and Drug Administration building is shown in Silver Spring, Md.  (AP Photo/Manuel Balce Ceneta, File) ** FILE **

FDA deploying ‘fast-track’ arsenal against COVID-19

Food and Drug Administration officials said in July that Pfizer's application for full approval of its COVID-19 vaccine would enjoy "priority review," and set a target deadline for finishing by January 2022. Published September 23, 2021

In this Sept. 14, 2021, file photo, a syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa. An influential panel of advisers to the Centers for Disease Control and Prevention met on Wednesday, Sept. 22, to decide who should get COVID-19 booster shots and when. (AP Photo/Matt Rourke)

FDA backs Pfizer COVID-19 boosters for seniors, high-risk persons

The Food and Drug Administration late Wednesday authorized boosters shots of the Pfizer-BioNTech vaccine for emergency use in seniors, persons at high risk from COVID-19 and those whose jobs make them more likely to get infected. Published September 22, 2021

Secretary of Homeland Security Alejandro Mayorkas speaks during a news conference at The National Press Club in Washington, on Thursday, Sept. 9, 2021. (AP Photo/Jose Luis Magana) ** FILE **

DHS chief Mayorkas pledges investigation into horseback incident in Texas

Homeland Security Secretary Alejandro Mayorkas said Tuesday that any mistreatment of a migrant is unacceptable and will be addressed with "full force" amid the uproar over border agents on horseback who wrangled Haitians and others near makeshift camps in Del Rio, Texas. Published September 21, 2021

In this March 26, 2021, file photo, a member of the Philadelphia Fire Department prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination site setup in Philadelphia. (AP Photo/Matt Rourke, File)

J&J says a second dose greatly enhances protection against COVID-19

Johnson & Johnson said persons who received a second dose of its COVID-19 vaccine enjoyed 94% protection against symptomatic disease, an increase from 74% under a one-shot regimen and a level on par with early studies of two-dose vaccines from Pfizer-BioNTech and Moderna. Published September 21, 2021